|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:subsidiary
|
|
gptkbp:acquiredBy
|
gptkb:Roche
|
|
gptkbp:acquisitionYear
|
2009
|
|
gptkbp:ceasedPublicTrading
|
2009
|
|
gptkbp:CEO
|
gptkb:Alexander_Hardy
|
|
gptkbp:city
|
gptkb:South_San_Francisco
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focusArea
|
immunology
neuroscience
oncology
ophthalmology
|
|
gptkbp:foundedBy
|
gptkb:Herbert_Boyer
gptkb:Robert_Swanson
|
|
gptkbp:foundedYear
|
1976
|
|
gptkbp:headquartersLocation
|
gptkb:South_San_Francisco,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Genentech
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:logo
|
Genentech logo.svg
|
|
gptkbp:notableAchievement
|
first company to produce synthetic human insulin
pioneer in recombinant DNA technology
|
|
gptkbp:notableEmployee
|
gptkb:Jennifer_Doudna
gptkb:Marc_Tessier-Lavigne
gptkb:Herbert_Boyer
gptkb:Napoleone_Ferrara
gptkb:Hal_Barron
gptkb:Dennis_Slamon
gptkb:Art_Levinson
gptkb:David_Goeddel
gptkb:Richard_Scheller
gptkb:Susan_Desmond-Hellmann
|
|
gptkbp:notableProduct
|
gptkb:Lucentis
gptkb:Xolair
gptkb:Activase
gptkb:Avastin
gptkb:Herceptin
gptkb:Kadcyla
gptkb:Perjeta
gptkb:Rituxan
|
|
gptkbp:numberOfEmployees
|
over 13,000
|
|
gptkbp:parentCompany
|
gptkb:Roche
|
|
gptkbp:researchInterest
|
rare diseases
biopharmaceuticals
monoclonal antibodies
cancer therapeutics
|
|
gptkbp:state
|
gptkb:California
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:gene
|
|
gptkbp:type
|
gptkb:subsidiary
|
|
gptkbp:website
|
https://www.gene.com/
|
|
gptkbp:bfsParent
|
gptkb:Aviv_Regev
gptkb:麻省理工學院
|
|
gptkbp:bfsLayer
|
4
|